跳转至内容
Merck
CN

1500218

USP

帕罗西汀 盐酸盐

United States Pharmacopeia (USP) Reference Standard

别名:

帕罗西汀 盐酸盐 半水合物, (3S-反式)-3-\ [(1,3-苯并二氧戊环-5-氧基)甲基]-4-(4-氟苯基)哌啶 盐酸盐 半水合物

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C19H20FNO3 · HCl · .5 H2O
化学文摘社编号:
分子量:
374.83
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

帕罗西汀 盐酸盐, United States Pharmacopeia (USP) Reference Standard

InChI key

QRQSGFFISBKLMZ-YHOFXEKLSA-N

SMILES string

O.Cl[H].Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3

InChI

1S/C19H20FNO3.ClH.H2O/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;;/h1-6,9,14,17,21H,7-8,10-12H2;1H;1H2/t14-,17-;;/m0../s1

grade

pharmaceutical primary standard

API family

paroxetine

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

Gene Information

human ... SLC6A4(6532)

正在寻找类似产品? 访问 产品对比指南

Biochem/physiol Actions

盐酸帕罗西汀半水化合物是选择性 5-羟色胺再摄取抑制剂 (SSRI) 中作用最强、选择性最强的一种;抗抑郁药
选择性 5-羟色胺再摄取抑制剂;抗抑郁药

Analysis Note

这些产品仅供测试和分析使用。它们不适用于人类或动物的给药,不可用于诊断、治疗或治愈任何疾病。

Application

盐酸帕罗西汀USP标准品的预期用途是USP规定的指定质量测试和检测。

General description

本品按现行药典规定交付。该产品的所有支持信息,包括SDS和任何产品信息宣传页均由药典发行机构制定并发布。如需更多信息和支持,请见现行药典的网站。
盐酸帕罗西汀是一种苯基哌啶衍生物,是选择性5-羟色胺再摄取抑制剂。其蛋白质结合能力高。该产品有两种形式,非吸湿性半水合物和吸湿性无水合物。这种药物还被认为具有治疗男性早泄的作用。

Other Notes

可能适用相应的销售限制。

pictograms

Exclamation markEnvironment

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

C G McMahon et al.
International journal of impotence research, 11(5), 241-245 (1999-12-20)
To evaluate the efficacy of chronic and 'on demand' administration of paroxetine hydrochloride in the drug treatment of premature ejaculation (PE). Ninety-four normally potent men, aged 18-61 y (mean 39 y) with premature ejaculation were treated between January 1996 and
Solid-state forms of paroxetine hydrochloride.
Buxton, P. Christopher, Ian R. Lynch, and John M. Roe.
International Journal of Pharmaceutics, 42.1, 135-143 (1988)
Perinatal outcome following third trimester exposure to paroxetine.
Costei, Adriana Moldovan, et al.
Archives of Pediatrics & Adolescent Medicine, 156.11, 1129-1132 (2002)
E Di Girolamo et al.
Journal of the American College of Cardiology, 33(5), 1227-1230 (1999-04-08)
The purpose of the study was to determine whether the well tolerated serotonin reuptake inhibitor paroxetine hydrochloride could prevent vasovagal syncope in patients resistant to or intolerant of previous traditional therapies. Serotonergic mechanisms play a major role in the processes
Puja Panwar Hazari et al.
ChemMedChem, 9(2), 337-349 (2014-01-01)
A novel SiX-dipropargyl glycerol scaffold (X: H, F, or (18) F) was developed as a versatile prosthetic group that provides technical advantages for the preparation of dimeric radioligands based on silicon fluoride acceptor pre- or post-labeling with fluorine-18. Rapid conjugation

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持